Today’s landscape of diabetes care is fraught with challenges: it's a condition that's often misunderstood by both patients and the healthcare system, highly prevalent, financially burdensome and frequently mismanaged. To explore a new paradigm in addressing these issues, we're speaking with Chun Yong, the founder and CEO of Reach7 Diabetes Studios. Chun, a biomedical engineer from Georgia Tech with experience as a UX strategist at Coca-Cola, is applying his unique expertise to "reimagine how
Read More
Population Health Management (PHM) in Healthcare | News, Analysis, Insights - HIT Consultant
LifeMD Launches $299 Introductory Wegovy® Bundle for Self-Pay Patients in Collaboration with Novo Nordisk
What You Should Know:
- LifeMD, Inc., a provider of virtual primary care services announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide).
- The comprehensive package includes both the GLP-1 medication and access to LifeMD’s virtual weight management program. The initiative is part of LifeMD's collaboration with Novo Nordisk, announced last month, and leverages a recently completed integration with NovoCare® Pharmacy to offer
Read More
Headspace Unveils AI-Powered Stratified Care Model for the Workforce
What You Should Know:
- Headspace, a global leader in accessible and comprehensive mental health platforms announced the launch of its stratified care model for organizations.
- The new approach is powered by Ebb, Headspace's empathetic AI companion, and is designed to intelligently guide employees to the most appropriate level of mental health care within the Headspace ecosystem, moving beyond traditional Employee Assistance Program (EAP) models that often default to
Read More
HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing
What You Should Know:
- The U.S. Department of Health and Human Services (HHS) announced it is taking immediate action to implement President Donald J. Trump’s Executive Order, “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.”
- Under the leadership of President Trump, HHS Secretary Robert F. Kennedy Jr., and Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz, the Department has outlined specific targets for
Read More
Trump Budget Would Strip Medicaid from 1.2M Restaurant Workers
What You Should Know:
- As discussions around significant federal budget changes continue, a new report from One Fair Wage details the potentially severe consequences of proposed Medicaid cuts for low-wage restaurant and tipped workers.
- The report, "Serving While Sick: The Effect of Trump Medicaid and Benefits Cuts on Restaurant Workers & Public Health," released in May 2025, argues that these cuts could strip healthcare from over a million vulnerable workers, forcing
Read More
Telehealth: An Essential Bridge to Healthcare Equity for Rural Communities
Rural America faces a unique set of healthcare challenges. While 20% of Americans live in rural communities, only 10% of physicians practice in those areas, leading to shortages that drastically limit access to care. With the United States expecting to face a shortage of up to 86,000 physicians over the next decade and over half of the rural physician workforce already over the age of 55, these gaps are at risk of worsening over the coming years without the proper solutions to address
Read More
Trump Signs Executive Order to Lower US Drug Prices with MFN Policy
What You Should Know:
- President Donald J. Trump has signed a new Executive Order aimed at bringing the prices Americans and U.S. taxpayers pay for prescription drugs in line with those paid by comparable developed nations.
- The executive order introduces a "Most-Favored-Nation" (MFN) pricing model and directs multiple government agencies to take action against what the Administration terms unfair international pricing practices that inflate costs for American
Read More
AI Study Challenges Fears of Racial Bias in Prostate Cancer Care
What You Should Know:
- Artera, a company developing multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the publication of a significant validation study in the JCO Clinical Cancer Informatics.
- The study rigorously assessed Artera's MMAI model and confirmed its ability to perform similarly across different racial subgroups using data from diverse prostate cancer clinical trials.
Addressing the Challenge of AI Racial Bias
Read More
AI Shows Promise in Detecting Overlooked Breast Cancers Between Screenings, UCLA Study Reveals
What You Should Know:
- Artificial intelligence (AI) could play a crucial role in identifying breast cancers that develop between routine screening mammograms, potentially detecting them before they become more advanced and challenging to treat, according to a new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.
- The research suggests that integrating AI into breast cancer screening practices could lead to earlier treatment and improved
Read More
Mayo Clinic Study: Genetic Test Can Predict GLP-1 Nausea Side Effects
What You Should Know:
- A new study from Mayo Clinic, released this past weekend, signals a significant advancement in understanding and potentially mitigating the challenging side effects associated with popular GLP-1 agonist medications like Wegovy and Zepbound.
- Led by Mayo Clinic physician and obesity expert Andres Acosta, MD, PhD, the research reveals that it is now possible to predict which patients are most likely to experience gastrointestinal (GI) side effects,
Read More
